Press Releases

CAMBRIDGE, Mass., Oct 23, 2002 /PRNewswire-FirstCall via COMTEX/ -- Alkermes, Inc. (Nasdaq: ALKS) announced today that its corporate presentation at the MassOpps 4th Annual Investor Conference hosted by the Massachusetts Biotechnology Council will be webcast live on Monday, October 28, 2002 at 9:50am EST. The presentation will be webcast live and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 30 days.

Alkermes' senior management will present an overview of the company at 9:50am EST on Monday, October 28, 2002, from the Hilton Hotel, Boston Logan Airport, Boston, MA.

Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to the headquarters and research and manufacturing facilities in Cambridge, Massachusetts, the company has a manufacturing facility in Chelsea, Massachusetts and a research and manufacturing facility in Ohio.

Contact:
Rebecca Peterson
Director, Corporate Communications
Alkermes, Inc.
(617) 583-6378

CONTACT:
Rebecca Peterson, Director, Corporate Communications of Alkermes, Inc., +1-617-583-6378